Chidamide Combined With Cisplatin in Head and Neck Adenoid Cystic Carcinoma (HNACC)
Status:
Completed
Trial end date:
2021-06-02
Target enrollment:
Participant gender:
Summary
The investigators conducted this study to evaluate the efficacy of Chidamide combined with
cisplatin in recurrent or metastatic head and neck adenoid cystic carcinoma.